Education for Urology Professionals

For over 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the fields of urology and radiation oncology. Our library contains over 1,000 videos and presentations.

E. David Crawford, MD Editor-in-Chief

Practice Resources for Urology Professionals

For over 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the field of urology.

E. David Crawford, MD Editor-in-Chief

Join our Community

Latest Content Contributions

Our contributing faculty are leaders in their respective fields and drive innovations in urology. Explore their most recent additions.

Point-Counterpoint: Next Generation Sequencing vs. Standard Culture – Next Generation Sequencing

Seth K. Bechis, MD
Sep 2023

Seth K. Bechis, MD, expresses concerns with standard urine cultures and discusses the efficacy and efficiency of next generation sequencing.

Point-Counterpoint: Next Generation Sequencing vs. Standard Culture – Standard Culture

Karen L. Stern, MD
Sep 2023

Karen L. Stern, MD, reviews next generation sequencing (NGS) concerns, places for NGS in urology, and benefits of standard urine cultures.

PCa Commentary | Volume 181 – September 2023

Edward Weber, MD
Sep 2023

This Commentary discusses PSMA PET/CT staging of advanced prostate cancer and AI guidance in combining ADT with radiation therapy.

When Men with Prostate Cancer Get Prostatitis

J. Curtis Nickel, MD, FRCSC
Sep 2023

J. Curtis Nickel, MD, FRCSC, discusses the diagnosis, treatment, and outlook for prostate cancer patients with co-occurring prostatitis.

Germline Screening and Polygenic Risk Scores

Christopher J. Kane, MD, FACS
Sep 2023

Christopher J. Kane, MD, FACS, discusses the benefits and limitations of genetic testing for prostate cancer and its associated syndromes.

Physics of HDR Brachytherapy for Urologists

Firas Mourtada, MSE, PhD, DABR
Sep 2023

Dr. Firas Mourtada discusses HDR brachytherapy for prostate, workflow using TRUS real-time image guidance, and basic radiation safety.

Next Generation Learning Centers

The latest best practices from leading urologists, designed to create topic mastery.

Next Generation Health, Exercise and Wellness

Rusty Speidel
Nov 2020

Regular, consistent physical activity just might help reduce the symptoms of certain urological health issues, including urinary incontinence and erectile problems.

Next Generation High-Intensity Focused Ultrasound (HIFU)

Rusty Speidel
Sep 2020

High-intensity focused ultrasound, or HIFU, is an innovative, non-invasive treatment for a wide range of tumors and diseases and has been used for prostate cancer for over 20 years. HIFU uses an ultrasound transducer, similar to the ones used for diagnostic imaging, but with much higher energy.

Next Generation Microbiome and Urologic Infections

Rusty Speidel
Apr 2020

There is an abundance of evidence that the human microbiome plays an important and nuanced role in controlling human health, including metabolism, immunity, pain, psychological state, and cancer.

Next Generation Genomics and Biomarkers

Leonard G. Gomella, MD, FACS
Mar 2019

The role of genetic testing for prostate cancer risk is a rapidly changing area. Experts debate the indications of sending a patient on to genetic counseling for further potential screening for inherited prostate cancer risk. One major issue that needs to be addressed in the urology community today is recognizing the frequency of inherited mutations that...

Next Generation nmCRPC

David Utz
Dec 2018

Latest prostate cancer research is turning its focus on the M0 space. Many therapeutic options for castration-resistant prostate cancer are approved and used for metastatic castration-resistant prostate cancer (mCRPC), but fewer options exist for those with non-metastatic (NM) CRPC.

Next Generation Imaging

David Utz
Dec 2018

The role of imaging is paramount in this evolution by providing physicians with accurate information on both the presence and extent of prostate cancers. Developments in molecular imaging are paving the way for more physicians to diagnose cancer and apply relevant therapy.

Next Generation Androgen Deprivation Therapy

Celestia S. Higano, MD
Oct 2018

One of the major treatments for prostate cancer is androgen-deprivation therapy (ADT), and about 50% of prostate cancer patients are treated with ADT at some point in their disease. ADT is used most frequently for patients with local but advanced prostate cancer or metastatic prostate cancer.

Next Generation Nocturia

Kevin T. McVary, MD, FACS
Aug 2018

Nocturia is arguably the most bothersome lower urinary tract symptom and necessarily imposes a considerable burden on quality of life. The often-multifactorial etiologies contributing to nocturia obscure the establishment of a reliable diagnosis.

Bladder with low grade papillary urothelial carcinoma.

Next Generation UTUC

Seth P. Lerner, MD
Aug 2018

Upper tract urothelial carcinoma (UTUC) is cancer of the transitional urothelial cells that line the upper urothelial tract of the renal pelvis and ureter. This type of cancer accounts for between 5% and 10% of urothelial cancer cases.

Latest Features and Updates

Timely information from our GRU Editorial Team, such as newly published proceedings, upcoming events, and newsworthy activities from within the urology community.

ADT as Foundational Therapy, and the Need for Consensus on Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Feb 2023

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego; Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center; and Benjamin H. Lowentritt, MD, FACS, Director of Prostate Cancer Services for United Urology Group...

Presentations from the 33rd Annual International Prostate Cancer Update

Feb 2023

These lectures were presented during the 33rd Annual International Prostate Cancer Update in January 2023, in Vail, Colorado.

Presentations from the 6th International Bladder Cancer Update

Dec 2022

These lectures were presented during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.

Presentations from the 2nd Annual Advances in Men’s Health

Oct 2022

These lectures were presented during the 2nd Annual Advances in Men's Health in August 2022, in Big Sky, Montana.

ADT Side Effects: Cardiovascular Disease

Aug 2022

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego, discusses reinforcing consistent testosterone suppression in ADT and the role of triptorelin with Scott B. Sellinger, MD, President of Advanced Urology Institute and a Partner at Southeastern Urological...

Presentations from the 32nd Annual International Prostate Cancer Update

Apr 2022

These lectures were presented during the 32nd Annual International Prostate Cancer Update in March 2022, in Snowbird, Utah.

ADT as Foundational Therapy, and the Need for Consensus on Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Feb 2022

Treatment Options for Androgen Deprivation Therapy

Jan 2022

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego, discusses reinforcing consistent testosterone suppression in ADT and the role of triptorelin with Scott B. Sellinger, MD, President of Advanced Urology Institute and a Partner at Southeastern Urological...

Presentations from the 1st Annual Advances in Men’s Health

Oct 2021

These lectures were presented during the 1st Annual Advances in Men's Health conference in August 22-25, in Whitefish, Montana.

Presentations from the 31st Annual International Prostate Cancer Update

Aug 2021

These lectures were presented during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Lecture Series: Leveraging the Electronic Medical Record to Improve Prostate Cancer Care

Aug 2021

In a GRU exclusive series, Franklin Gaylis, MD, FACS, discusses how the urology field can use the electronic medical record, or EMR, to improve adherence to best medical practices in prostate cancer care.

Screening and Prevention of Prostate Cancer 2021 Series

Jul 2021

In a GRU exclusive series, Sigrid V. Carlsson, MD, PhD, MPH, discusses PSA screens, biopsy, and MRI for early detection.

Androgen Society 3rd Annual Meeting Review with Abraham Morgentaler, MD, FACS

Jul 2021

In a GRU exclusive, Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews lectures from all three days of the 3rd Annual Androgen Society meeting.

Presentations from the 4th International Bladder Cancer Update

May 2021

These lectures were presented during the 4th Annual International Bladder Cancer Update on April 28.

Active Surveillance 2021 with Laurence Klotz, MD, FRCSC

Mar 2021

In a GRU exclusive, Laurence Klotz, MD, FRCSC, Professor of Surgery and holder of the Sunnybrook Chair of Prostate Cancer Research at the University of Toronto, gives three Platinum Lectures on the current state of active surveillance for prostate cancer.

Presentations from the Virtual Southwest Prostate Cancer Symposium

Jan 2021

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

Presentations from Perspectives in Urology Point-Counterpoint Virtual 2020

Dec 2020

These lectures were presented during the Perspectives in Urology Point • Counterpoint Virtual Conference on November 11, 2020.

Presentations from the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

Dec 2020

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

Southwest Prostate Cancer Symposium

Nov 2020

The 2020 Virtual Southwest Prostate Cancer Symposium (SPCS 2020) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices.

2020 Virtual Future Directions in Urology Symposium Presentations

Oct 2020

These lectures were presented during the 2020 Virtual Future Directions in Urology Symposium on August 10, 2020.

Upcoming Live & Virtual Events

Plan your next urology meeting, CME activity or virtual conference now.

23rd Future Directions in Urology Symposium

The Broadmoor
Colorado Springs, Colorado
August 12-14, 2022

27th Annual Innovations in Urologic Practice

Inn and Spa at Loretto
Santa Fe, New Mexico
September 22-24, 2023

11th Urology Today Conference

Grove Park Inn
Asheville, North Carolina
October 27-29, 2023

View All